Literature DB >> 6336659

Biological behavior of human breast carcinoma-associated antigens expressed during cellular proliferation.

D W Kufe, L Nadler, L Sargent, H Shapiro, P Hand, F Austin, D Colcher, J Schlom.   

Abstract

The cell surface-binding properties of two murine monoclonal antibodies reactive with human mammary tumor cells are described. Fluorescence-activated cell sorter analyses demonstrate that both monoclonal antibodies, B6.2 and B38.1, are reactive with the surface of the majority of human breast tumor cell lines tested but are unreactive with a variety of normal human cell lines, melanomas, sarcomas, and lymphoid tumors. Antibody B6.2 was also reactive with selective carcinomas, while antibody B38.1 showed even broader reactivity. The two monoclonal antibodies were unreactive with the surface of a variety of normal human tissues obtained at biopsy, including lymph nodes, bone marrow, and spleen, but were reactive with mammary tumor cells obtained from four of six pleural effusions. Surface binding to mammary tumor cells by both monoclonal antibodies was shown to decrease during density-dependent arrest; further cell cycle analysis demonstrated differential antibody surface binding during S phase. Prolonged exposure of mammary tumor cells to antibody showed no evidence of antigen capping or internalization. Both monoclonal antibodies were shown to lyse mammary tumor cells in antibody-dependent cell-mediated cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6336659

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

2.  Heterogeneous expression of a murine B16 melanoma-associated antigen correlates with cell cycle.

Authors:  S P Leong; P D Noguchi; R E Cunningham; T Takami; J A Roth
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  Monoclonal antibodies of predefined specificity detect activated ras gene expression in human mammary and colon carcinomas.

Authors:  P H Hand; A Thor; D Wunderlich; R Muraro; A Caruso; J Schlom
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

4.  Immunohistochemical reactivity of a monoclonal antibody prepared against human breast carcinoma.

Authors:  R Mariani-Costantini; M I Colnaghi; F Leoni; S Mènard; S Cerasoli; F Rilke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

5.  The immunohistochemical reactivity of a new anti-epithelial monoclonal antibody (MAb b-12) against breast carcinoma and other normal and neoplastic human tissues.

Authors:  H R Zenklusen; C Stähli; F Gudat; J von Overbeck; J Rolink; P U Heitz
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

6.  In vitro and in vivo pharmacology and pharmacokinetics of a human engineered monoclonal antibody to epithelial cell adhesion molecule.

Authors:  W Steve Ammons; Robert J Bauer; Arnold H Horwitz; Zhi J Chen; Eddie Bautista; Harry H Ruan; Marina Abramova; Kristen R Scott; Russell L Dedrick
Journal:  Neoplasia       Date:  2003 Mar-Apr       Impact factor: 5.715

7.  Parameters involved in the enhancement of monoclonal antibody targeting in vivo with recombinant interferon.

Authors:  F Guadagni; J Schlom; S Pothen; S Pestka; J W Greiner
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

8.  Mucin-like cancer-associated antigen (MCA) compared with CA 15-3 in advanced breast cancer.

Authors:  G G Steger; R Mader; K Derfler; K Moser; C Dittrich
Journal:  Klin Wochenschr       Date:  1989-08-17

Review 9.  Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies.

Authors:  P A Edwards
Journal:  Br J Cancer       Date:  1985-02       Impact factor: 7.640

10.  Prognostic value of a novel circulating serum 90K antigen in breast cancer.

Authors:  S Iacobelli; P Sismondi; M Giai; M D'Egidio; N Tinari; C Amatetti; P Di Stefano; C Natoli
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.